Quanterix (QTRX) EBITDA Margin (2017 - 2026)
Quanterix (QTRX) posted EBITDA Margin of 113.59% for Q1 2026, down 101.26% on a QoQ basis from 56.44% in Q4 2025, and down 2666.0% year-over-year from 4.43% in Q1 2025.
Quanterix (QTRX) EBITDA Margin (2017 - 2026) Analysis & Trends
Quanterix's EBITDA Margin history runs 10 years deep, the most recent figure standing at 113.59% for Q1 2026.
- Quarterly EBITDA Margin fell 2666.0% year-over-year to 113.59% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 96.94% (down 4990.0% YoY) and the FY2025 annual result came in at 90.38%, down 5210.0% from the prior year.
- EBITDA Margin was 113.59% for Q1 2026 at Quanterix, down from 56.44% in the prior quarter.
- Across five years, EBITDA Margin topped out at 29.18% in Q2 2023 and bottomed at 151.58% in Q2 2025.
- A 5-year average of 70.94% and a median of 56.44% in 2025 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin soared 10186 bps — and 2025, when it tumbled 11975 bps.
- Quanterix's EBITDA Margin stood at 82.84% in 2022, then jumped by 48 bps to 43.16% in 2023, then advanced by 3 bps to 42.0% in 2024, then plunged by 34 bps to 56.44% in 2025, then sank by 101 bps to 113.59% in 2026.
- Business Quant data shows QTRX's EBITDA Margin at 113.59% in Q1 2026, 56.44% in Q4 2025, and 92.77% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Quanterix | 184.16 Mn | 84.89 Mn | 15.57 Mn | -113.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -113.59% |
| Dec 31, 2025 | -56.44% |
| Sep 30, 2025 | -92.77% |
| Jun 30, 2025 | -151.58% |
| Mar 31, 2025 | -86.92% |
| Dec 31, 2024 | -42.00% |
| Sep 30, 2024 | -32.80% |
| Jun 30, 2024 | -31.83% |
| Mar 31, 2024 | -47.27% |
| Dec 31, 2023 | -43.16% |
| Sep 30, 2023 | -40.58% |
| Jun 30, 2023 | -29.18% |
| Mar 31, 2023 | -37.17% |
| Dec 31, 2022 | -82.84% |
| Sep 30, 2022 | -142.44% |
| Jun 30, 2022 | -114.74% |
| Mar 31, 2022 | -60.75% |
| Dec 31, 2021 | -58.87% |
| Sep 30, 2021 | -55.01% |
| Jun 30, 2021 | -53.87% |